Catalyst Pharmaceutical
CPRX
CPRX
50 hedge funds and large institutions have $49.3M invested in Catalyst Pharmaceutical in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
7% less funds holding
Funds holding: 54 → 50 (-4)
Holders
50
Holding in Top 10
–
Calls
$412K
Puts
–
Top Buyers
| 1 | +$5.19M | |
| 2 | +$1.17M | |
| 3 | +$1.08M | |
| 4 |
Renaissance Technologies
New York
|
+$746K |
| 5 |
DMK
David M. Knott
|
+$554K |
Top Sellers
| 1 | -$2.72M | |
| 2 | -$794K | |
| 3 | -$599K | |
| 4 |
Millennium Management
New York
|
-$506K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$63K |